Skip to main content
  1. Market Insights
  2. Health
  3. Pharmaceuticals

Other Pharmaceuticals - Portugal

Portugal
  • Revenue in Portugal's Other Pharmaceuticals market is projected to reach US$970.20m in 2024.
  • The market is expected to show an annual growth rate (CAGR 2024-2029) of 0037, resulting in a market volume of US$1.19bn by 2029.
  • In global comparison, United States is set to generate the highest revenue, reaching US$260.50bn in 2024.
  • Portugal's pharmaceutical market is experiencing a rise in demand for alternative medicines and natural remedies.

Definition:
The market Other Pharmaceuticals covers revenues for areas that are not specifically mentioned in the other markets, such as psychotropic or gastroenterology drugs and less expensive but widely used drugs, such as cold and cough remedies or analgesics.

Additional information:
Market values represent the revenues generated by manufacture prices paid to primary vendors, either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), companies (B2B), and governments (B2G).

In-Scope

  • Psychotropic drugs
  • Gastroenterology
  • Cold and cough remedies
  • Antibiotics
  • Women's health
  • Analgesics

Out-Of-Scope

  • Veterinary drugs
  • Medical devices
Pharmaceuticals: market data & analysis - Cover

Market Insights report

Pharmaceuticals: market data & analysis

Study Details

    Revenue

    Notes: Data shown is using current exchange rates and reflects market impacts of the Russia-Ukraine war.

    Most recent update: Jun 2024

    Source: Statista Market Insights

    Notes: The chart “Comparable Estimates” shows the forecasted development of the selected market from different sources. Please see the additional information for methodology and publication date.

    Most recent update: Mar 2024

    Analyst Opinion

    The Other Pharmaceuticals market in Portugal has seen significant growth in recent years.

    Customer preferences:
    Customers in Portugal have shown a growing interest in alternative medicines and natural remedies, leading to an increased demand for Other Pharmaceuticals. This trend is in line with the global shift towards more natural and holistic approaches to healthcare.

    Trends in the market:
    The Other Pharmaceuticals market in Portugal has been growing steadily due to the increasing demand for alternative medicines. Additionally, the aging population in Portugal has led to a rise in chronic diseases, which has further boosted the demand for Other Pharmaceuticals.

    Local special circumstances:
    Portugal has a well-established healthcare system, which has helped to support the growth of the Other Pharmaceuticals market. The country also has a strong tradition of using natural remedies, which has made it easier for alternative medicines to gain acceptance among the population.

    Underlying macroeconomic factors:
    The Portuguese economy has been recovering from the financial crisis of the late 2000s, which has led to an increase in disposable income and a greater willingness to spend on healthcare. Additionally, the government has been investing in healthcare infrastructure, which has helped to support the growth of the Other Pharmaceuticals market.

    Next generation therapy

    Notes: Data shown is using current exchange rates and reflects market impacts of the Russia-Ukraine war.

    Most recent update: Sep 2024

    Source: Statista Market Insights

    Global Comparison

    Most recent update: Jun 2024

    Source: Statista Market Insights

    Methodology

    Data coverage:

    Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

    Modeling approach / Market size:

    Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

    Forecasts:

    In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

    Additional notes:

    Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.

    Health

    Access more Market Insights on Health topics with our featured report

    Pharmaceuticals: market data & analysis - BackgroundPharmaceuticals: market data & analysis - Cover

    Key Market Indicators

    Notes: Based on data from IMF, World Bank, UN and Eurostat

    Most recent update: Sep 2024

    Source: Statista Market Insights

    Explore more high-quality data on related topic

    Global pharmaceutical industry - statistics & facts

    The global pharmaceutical industry has experienced significant growth during the past two decades, with revenues totaling around 1.6 trillion U.S. dollars in 2023. With growth like that, the industry's size is now comparable to the gross domestic products (GDPs) of countries like Spain, Mexico, or Australia.
    More data on the topic

    Contact

    Get in touch with us. We are happy to help.